Adherence Challenges for High-Efficacy MS Therapies
Published on Fri, 22 May 2020
High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates
High-efficacy disease-modifying treatments (DMDs) for relapsing-remitting multiple sclerosis offer better relapse suppression and disability control but come with significant safety concerns, intensive long-term monitoring, and complex administration protocols.
An expert opinion from the UAE underscores the importance of balancing treatment efficacy and patient preferences. Barriers like side effects, route of administration, and adherence need careful management to ensure optimal therapy outcomes. Understanding patient priorities is key to overcoming adherence challenges with newer, high-efficacy DMDs.